New research attempts to answer some of the mystery related to the causes and impact of hypercalcemia in patients with newly diagnosed multiple myeloma. Hypercalcemia is caused by many factors in ...

Please provide your email address to receive an email when new articles are posted on . A new clinical practice guideline from the Endocrine Society recommends treatment with IV bisphosphonates or ...

Hypercalcemia of malignancy (HCM) is the most common metabolic complication seen in patients with cancer, and is associated with a high degree of morbidity and mortality. It affects an estimated 2%–30 ...

Calcium is an important nutrient that your body needs to grow strong bones and keep you healthy. High blood calcium often does not cause any symptoms. But over time, very high calcium levels can cause ...

The authors used Ovid Medline to search for human trials on hypercalcemia and furosemide from 1950 to April 2008, and articles related to bisphosphonates and hypercalcemia during the same period.

If your doctor tells you that you have hypercalcemia, it means you have too much calcium in your blood. The possible causes of high calcium levels include more than 25 diseases, as well as some ...

Familial hypocalciuric hypercalcemia: It is a condition which is hereditary and runs in families and is characterized by 3 things – hypercalcemia (S.Ca >10.2 mg/dl), hypocalciuria (Ca excretion rate 0 ...

Goldner 5 makes several important points in this review. First, the clinician must determine if the hypercalcemia is indeed a result of malignancy, rather than just associated with a nonmalignant ...

Searching for effective treatment options for 'Hypercalcemia symptom'? This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for ...

A 66-year-old woman was admitted to the hospital in April 2003 with fatigue and parathyroid hormone–mediated hypercalcemia, which was marked by progressively worsening hypercalcemia and ...

A 48-year-old woman was given a diagnosis of infiltrating ductal breast carcinoma (T2N1M0; grade I; positive for estrogen receptors, progesterone receptors and human epidermal receptor-2 [HER2] status ...